Showing posts with label Outlook. Show all posts
Showing posts with label Outlook. Show all posts

Friday, 14 October 2016

Global Cardiopulmonary Stress Testing Systems Market Driven by Increasing Prevalence of Coronary Artery Disease

Over the past few years, cardiopulmonary exercise testing (CPET) has been recognized as a vital clinical tool, used to assess exercise capacity in patients and predict various cardiac conditions. CPET provides the assessment of integrative exercise response including cardiovascular, pulmonary, and skeletal muscle systems. Since the developments in the technology, cardiopulmonary stress testing systems are being consistently used in many clinical applications.
Changes in the lifestyle, stressful life, and lack of exercise have led to the growing obese population. This has led to the growth of cardiac patients, which has, in turn, increased the acceptance of cardiopulmonary stress testing systems. Transparency Market Research (TMR), in its new report, states that the global cardiopulmonary stress testing systems market was valued at US$3.30 bn in 2014 and is predicted to reach US$6.67 bn by 2023, expected to progress at an 8.20% CAGR from 2015 to 2023.
TMR experts answer a few important questions based on the global cardiopulmonary stress testing systems, which the readers would like to know:
Q. How is obesity the most important driving factor for the global cardiopulmonary stress testing systems market?
The modern lifestyle and the increasing habit of eating junk food have led to significant growth of obese people. The increasing cases of obesity have led to the increase in cardiac disorders. Currently, North America records the highest number of obese people. However, the number of obese people is expected to increase in Asia Pacific in the years to come. The global rise in the obese people is expected to be the most important factor driving the global cardiopulmonary stress testing systems market.
Q. Will technology plan an important role in the development of the global market?
Yes, technology has helped towards the development of many industries, and the global cardiopulmonary stress testing systems market is not an exception. Technological advancements in cardiopulmonary stress testing systems have enhanced the functional parameters, which is likely to propel the global market. Key companies operating in the global cardiopulmonary stress testing systems market are aiming to adopt new technologies for the development of new systems.
Q. How will the global market be affected by the rising occurrence of cardiovascular diseases?
The occurrence of cardiovascular diseases is been increasing since the recent past, which has been one of the driving factors for the global market. As per the World Health Organization, the coronary artery disease accounts for 64% of the total global deaths occurring from cardiovascular conditions. This has thus been recognized as one of the primary causes of average quality of life for a majority of the global population.
It is always boosting to see researchers investing more towards the development of new products. Recently, a women’s special hospital in Boston showed interest in developing new cardiopulmonary stress testing systems.
With many leading players showing interest and efforts towards the development of new cardiopulmonary stress testing systems, the global market is expected to show promising growth opportunities across many regions. The presence of key equipment manufacturers of cardiopulmonary stress testing systems, the application of laws including the Affordable healthcare Act, and the high awareness among people are some of the factors expected to propel the global cardiopulmonary stress testing systems market in the near future.

Friday, 12 August 2016

Global Home Healthcare Market to Expand at 8.10% CAGR from 2014 to 2020 owing to Rising Prevalence of Chronic Diseases

The risk for hypertension, end-stage kidney diseases, stroke, respiratory and other chronic diseases is rising constantly worldwide. For example, in 2012, International Union Against Tuberculosis and Lung Disease stated that asthma affects nearly 235 million people worldwide and the number is projected to increase in near future. Home healthcare business offers precision-based model for personal care of these types of chronic diseases and is witnessing high acceptance among patient population. Increasing sedentary lifestyle and aging population globally would surge the demand of home healthcare devices and services market. However, accuracy and limited geographic presence of service providers are some of the factors that restrict the growth of this market. For example, home healthcare service providers like The Linde Group and Gentiva Health Services, Inc. has limited market geographic presence in economies like Asia-Pacific, Russia and Latin America. The global home healthcare market is estimated to be USD 176,107.9 million in 2013 and is expected to reach USD 303,605.9 million by 2020, growing at a CAGR of 8.1% from 2014 to 2020.
The market of global home healthcare market is categorized as device types and services. Home healthcare devices market is segmented as diagnostics and monitoring home healthcare devices, therapeutics home healthcare devices, mobility assist devices and medical supplies. The market for diagnostics and monitoring devices segment accounted for the largest share owing to rising prevalence of chronic diseases coupled with increasing healthcare awareness. However, therapeutics home healthcare devices segment is expected to grow at the highest CAGR of over 10% from 2014 to 2020. Introduction of advanced and easy to use therapeutics home healthcare devices will help this segment to record highest CAGR.
Services segment in the global home healthcare market accounted for the largest share in 2013. This dominance was majorly due to the presence of large number of home healthcare service providers and strong acquisition strategies of these healthcare service providers. For example, in October 2013, Gentiva Health Services, Inc. acquired Harden Healthcare Holdings, Inc., a healthcare service provider. The company acquired all the three business units of Harden Healthcare Holdings, Inc. namely, home health, hospice and community business. This acquisition would help the company to offer better healthcare services to their customers. Home healthcare services segment is categorized as rehabilitation, telehealth and telemedicine, respiratory therapy, infusion therapy and unskilled home healthcare services.
Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=300
Global home healthcare market, by geography is segmented as North America, Europe, Asia-Pacific and Rest of the World. In 2013, North America dominated the global home healthcare market. Favorable reimbursement policies coupled with presence of large number of small scale and large scale healthcare service providers in the region stimulates the growth of home healthcare market in North America. Europe accounted for the second largest share i.e. around 25% of the total market in 2013. High prevalence of diabetes and cardiovascular diseases and increasing healthcare investments by the European government supports the growth of home healthcare market. The home healthcare market in Asia-Pacific is expected to grow at the highest CAGR of more than 7% from 2014 to 2020. The growth of this market is mainly due to the introduction of new technologies and incessant product launch by key companies in Asia-Pacific market.
Some of the prominent players in the global home healthcare market are F. Hoffmann-La Roche Ltd, Teleflex Corporation, Phillips Healthcare, Medtronic, Inc, Abbott Laboratories, Omron Healthcare, Inc., Praxair Technologies, Inc., Bayer Healthcare, ResMed, Inc., GE Healthcare, Cardinal Health, Gentiva Health Services, Inc., Invacare Corporation, Johnson & Johnson and others.

Wednesday, 13 April 2016

Hematology Diagnostics Market to See Good Times Ahead

laboratory-1149152_640In a report, titled “Hematology Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” Transparency Market Research presents a comprehensive overview of the factors impacting the growth trajectory of the global market for hematology diagnostics between 2015 and 2023.
Hematology is a branch of medicine dealing with the diagnosis, treatment, and prevention of ailments related to the bone marrow, blood, immunology, the vascular system, and hemostasis (blood clotting). Hematological tests are carried out to diagnose various blood-related diseases such as anemia, leukemia, blood cancer, and autoimmune disorders, among others. The method encompasses various in vitro diagnostic (IVD) techniques such as hemostasis, molecular diagnostics, blood analysis, flow cytometry, and immunodiagnostics, which help in measuring various parameters of blood with improved precision at a comparatively lower cost.
The increasing incidence of blood-related disorders has been a key factor driving the global market for hematology diagnostics. As per data released by the Leukemia & Lymphoma Society (LLS), in the U.S. alone, approximately 1.6 million new cases of cancer were reported in 2015. About 9.8% of this demographic were diagnosed with leukemia, lymphoma, and myeloma. Additionally, as per the findings of the National Hemophilia Foundation, approximately 400,000 cases of people suffering from hemophilia are registered globally. With the population of people aged above 65 years being projected to reach over 83.7 million by 2050, as per the Administration for Community Living, which is twice that estimated in 2012, the market for hematology diagnostics is anticipated to exponentially grow in the near future.
It is therefore extremely important for vendors operating in the market for hematology diagnostics to be well aware of the market’s present dynamics and how various factors will shape its future. The information comprised in the report is aimed at assisting the market stakeholders with insights pertaining to the prevailing trends and projected factors that may influence the market’s growth trajectory over the forecast period.
Providing in-depth information pertaining to the technological developments and government policies supporting the further development of healthcare infrastructure across the most lucrative regions, the report makes for a resourceful guidebook for those seeking pertinent information about the hematology diagnostics market.
The report broadly classifies the global hematology diagnostics market on the basis of end user, product, and geography. By product, the market is bifurcated into hematology reagents and hematology analyzers. Based on end user, the market is segmented into clinical laboratories, hospitals, research institutes, and academics institutes.
Regionally, the global hematology diagnostics market constitutes Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Of these, North America presently dominates the global hematology diagnostics market. However, the market in Asia Pacific is expected to exhibit the highest CAGR during the forecast period.
To provide a holistic overview of the prevailing competitive scenario of the market for hematology diagnostics, the report profiles some of the most prominent vendors operating in the market, such as HemoCue AB, Beckman Coulter, Sysmex, Abbott Laboratories, Mindray Medical HORIBA, Ltd., International Limited., Roche Diagnostics A/S, Siemens AG, and Bio-Rad Laboratories, Inc.

Tuesday, 22 March 2016

Wound Care Market Witnesses Rising Demand and Investment from R&D Activities

Wound Care MarketTransparency Market Research presents a new market study on the global wound care market for the 2014-2020 period. The report, titled “Wound Care Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast 2014 – 2020,” studies the global wound care market as a whole with a focus on the China market for the same. The report covers vital market indicators such as growth drivers, growth restraints, consumer trends, product portfolio, and size projections of this market for the forecast period.
Using validated analytical tools such as Porter’s five forces analysis, the report anticipates the future outlook of the global as well as China market. The bargaining power of suppliers and buyers, degree of competition in the future, threat from alternative products, and threat from new entrants are examined via the Porter’s five forces model. In the company profile section of the report, insights into the leading players in the wound care market are provided with respect to pipeline products, new initiatives, financial status, breakthroughs, mergers and acquisitions, etc.
The wound care market is progressing expeditiously, says the report. This is because product manufacturers are consistently introducing innovative products for healing of injuries and to prevent infections in wounds and abrasions. These initiatives are also supported by government initiatives in the form of expert guidance for innovative products and funding of projects partially. In addition, the rising incidence of hospital-acquired infections, advances in chemical and biological sciences, and the use of innovative materials for wound care products are favoring the market’s growth.
On the contrary, the growth of this market is impeded due to certain factors. The high cost of design and manufacture of advanced wound care products and the increasing degree of competition are conspicuous impediments to this market. With the presence of new entrants in the global and China market for wound care, existing market participants need to develop cutting-edge products to survive the competition in this market.
The global wound care market is categorized on the basis of product type and geography. The product type segments of the market are basic, bioactive, therapy, advanced, and traditional. The components of the advanced wound care market are moist wound care, foam wound care, hydrogels, alginates, and hydrocolloid. Amongst all, the bioactive product segment will display the highest growth rate in the global and China market during the forecast period.
Region-wise, North America, Europe, Asia Pacific, and Rest of the World are the segments of the global wound care market. Whilst, currently, North America is the clear leader in the global wound care market, Asia Pacific will register the highest growth rate in this market in the coming years.
Top companies operating in the global wound care market mentioned in this report are Baxter International Inc., Smith & Nephew, Coloplast AS, Hollister Inc., Covidien PLC, 3M Company, Derma Sciences Inc., and others.

Friday, 18 March 2016

A brief review of Anti-Adhesion Products Market

Pharmaceuticals_01Adhesion is one of the common problems affecting almost 55% to 90% patients followed by surgery. Adhesion is a band of scar tissue formed between organs and tissue after a surgery as a part of a normal healing process. However, when it connects wrong tissues into each other, adhesions may lead to severe clinical symptoms such as pelvic pain, intestinal blockage, infertility and loss of sensation depending on the location and size of the adhesions. Adhesions are most common after surgeries such as abdominal surgery, thoracic surgery, gynaecological surgery and plastic surgery. After abdominal surgery, bowels and pelvic organs may adhere with each other as a result of adhesion causing risks for small bowel obstruction and severe pain. The various types of adhesions based on their locations are abdominal adhesions, intestinal adhesions, intraperitoneal adhesions and pelvic adhesions.
Some of the anti-adhesion products available in the market are Adept (Baxter), Seprafilm (Genzyme), INTERSEED (Johnson & Johnson) and Surgiwrap (MAST Biosurgery). The market for anti-adhesion products can be segmented on the basis of types of surgery such as abdominal surgery, gynecological surgery and other surgical procedures. The market for anti-adhesion products is growing due to large number incidences of adhesion associated with various surgeries. Usually 55% to 90% patients undergoing abdominal and gynecological surgeries face adhesion problems. Presently, North America represents the largest market as a number of products have been approved by FDA. Asia-Pacific is experiencing growth as large number of patients are undergoing abdominal and gynecological surgeries. In the coming future the market will witness growth with the introduction of new products with more efficacy.
Some of the major vendors operating in this market are Johnson & Johnson, Baxter International, WL Gore, Anika Therapeutics, Inc., Angiotech Pharmaceuticals, Inc., Genzyme Corporation, LifeCell Corporation and MAST Biosurgery AG.

Thursday, 17 March 2016

Advanced Remote Patient Monitoring Systems Market Segment Forecast up to 2020

hospital-840135_1280Remote patient monitoring systems refer to a technology that enable monitoring of patients outside the conventional clinic or hospital premises. The main concept behind remote patient monitoring is to avoid the inconvenience caused to critical patients. Advanced remote patient monitoring systems include sophisticated peripherals that facilitate real time audio and video service. This enables face to face interaction between the patients and medicine professionals. These systems are highly useful as it reduces the travel time of patients to clinics and improves the medical consultation. This can reduce mortality rates and enable efficient use of medical resources. The connectivity between the patients and medical professionals is attained using wireless technologies such as wireless local area networks (WLAN) and cellular networks. Advanced remote patient monitoring systems helps in avoiding emergency overcrowding, manage large number of patients and improved maintenance of electronic health records (EHR).
One of the major factors driving the advanced remote patient monitoring systems market is low treatment costs. Advanced remote patient monitoring systems reduce the expenses such as hospital admissions, travelling costs and others. Increasing number of patients with diseases such as diabetes, congestive heart diseases and others is major factor driving the demand for advanced and cost effective healthcare solutions. Monitoring systems deliver low cost, fast and reliable consulting of these diseases as compared to conventional consulting. Furthermore, advanced remote patient monitoring systems help the medical professional to monitor number of patients simultaneously from one place. This enables increased coverage of patient monitoring with less number of medical personnel.
With continuous monitoring of patients, the medical professionals can diagnose serious disorders in an early stage. This leads to improved patient care and reduced mortality rate. Furthermore, increasing adoption of mobile devices such as smartphones, tablet personal computers (PCs) and others is another factor boosting the advanced remote patient monitoring systems market.
The advanced remote patient monitoring systems market is segmented based on the type of monitoring, end-user and geographic regions. The different types of monitoring include vital signs monitoring, diagnostic monitoring and specialized monitoring. Vital sign monitoring comprises blood pressure, pulse oximeters and other physical parameters. Diagnostic monitoring includes electrocardiogram (ECG) and others. Specialized monitoring includes disease specific monitoring such as anesthesia, diabetes - glucose, cardiac rhythm, respiratory and other disorder monitoring. The advanced remote patient monitoring systems market is segmented based on end-users as hospital based patients and telemedicine patients. Geographically, the advanced remote patient monitoring systems market is segmented into four major regions as North America, Europe, Asia Pacific and Rest of the World (RoW). At present, North America accounts for the largest share in terms of revenue in advanced remote patient monitoring systems market. This is mainly due to rising lifestyle diseases such as atherosclerosis, asthma, osteoporosis and other heart diseases. Additionally, availability of sophisticated monitoring devices is another factor responsible for this growth. North America is expected to remain the dominant market for the next few years owing to high investment in healthcare sector.
Some of the leading players in advanced remote patient monitoring systems market include Abbott Laboratories, Drager Medical GmbH, Covidien Ltd., GE Healthcare, Masimo Corporation, Johnson and Johnson Inc., Mindray Medical International Ltd., Natus Medical Inc., Mortara Instrument Inc., Nihon Kohden Corporation, Omron Healthcare Co. Ltd., Nonin Medical Inc., Koninklijke Philips N.V., Roche Diagnostics Ltd. and others.

Tuesday, 1 March 2016

Things to know about Disposable Pain Pumps Market

Disposable Pain PumpA featured report, titled “Disposable Pain Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” from Transparency Market Research (TMR) offers a 360-degree view of the market. The report offers an extensive coverage of the key trends and their impact on the global disposable pain pumps market.
Pain pumps/intrathecal drug delivery is a technique of delivering medication, such as delivering an opioid directly to the spinal cord. A pain pump system consists of a small pump placed surgically under the abdominal skin. This pump delivers the drug using a catheter to the area around the spinal cord. These pumps are used when all other traditional methods have failed to provide relief to patients suffering from chronic pain. With the pain relief drug delivered directly to the spinal cord, the amount of dose required is much lower as compared to that of oral medication.
Disposable pain pumps can be programmed to release small doses of medication over a period of time. Furthermore, they can also be programmed to provide the pain relief medication in varying amount at different times of the day as per the needs of the patient. A pain pump’s reservoir can be refilled using a syringe or can be removed permanently. By application, the disposable pain pumps market is segmented into pain management and spasticity management.
The global disposable pain pumps market is driven by the rising number of patients suffering from cancer pain and chronic pain. Other trends such as the significant reduction in the pain caused by failed back surgery syndrome and the rising prominence of reflex sympathetic dystrophy will also benefit the global disposable pain pumps market. In addition to this, the benefits associated with disposable pain pumps such as allowing patients the ability to perform daily activities with ease, the ease of device removal, and low medication dose are also driving the market.
According to region, the global disposable pain pumps market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Currently, the global disposable pain pumps market is led by Europe and North America due to favorable trends in guidelines and protocols, clinical practice, regulatory affairs, reimbursement, and the competitive framework. Emerging economies in Latin America, Asia, and the Middle East are expected to witness high growth due to the growing awareness among consumers regarding these procedures.
The leading players operating in the global disposable pain pumps market are Alaris Medical Systems, Advanced Infusion, McKinley Medical, Sorenson Medical, Stryker, and Baxter International. Several companies in the global disposable pain pumps market have recently received approvals from the FDA. These include systems such as Medtronic’s SynchroMed(R) II Programmable Pump and Flowonix Medical’s Prometra drug delivery pump.

Monday, 1 February 2016

Hematology Diagnostics Market Outlook to 2023

Hematology refers to a branch of medicine, which is concerned, with the diagnosis, prevention, and treatment of diseases related to blood, bone marrow, vascular systems, immunology and hemostasis (i.e. blood clotting). Hematological tests can diagnosis various blood related diseases, anemia, leukemia, autoimmune disorders, and blood cancers among others. Hematology constitutes various in vitrodiagnostic (IVD) techniques such as, molecular diagnostics, hemostasis, blood analysis, histology, flow cytometry, and immunodiagnostics, which helps to measure more parameters in blood with a higher precision at comparatively lower cost.
The major factors driving the hematology diagnostics market include, rising incidences of blood related disorders, for instance as per the data stated by the Leukemia & Lymphoma Society (LLS) approximately 9.8% of the population in U.S. was diagnosed with leukemia, myeloma and lymphoma of the 1,658,370 new cases of cancer in 2015. Moreover, data from the National Hemophilia Foundation states that, worldwide approximately 400,000 cases are suffering from hemophilia. Population aged 65 and over isprojected to reach 83.7 million in 2050, which is twice that, estimated in 2012 as per the Administration for Community Living. In addition, technological advancements, government initiatives supporting healthcare infrastructure are some of the factors fueling the growth of the hematology diagnostics market.
Integration of flow-cytometry techniques in analyzers, developments in point of care (POC) hematology testing and introduction of digital imaging systems in labs and increasing use of microfluidics technology in analyzers are creating opportunities in the global hematology diagnostics market. Whereas, product recalls, high cost of hematology diagnostic instruments, lesser adoption in emerging economies and poor health insurance and reimbursement coverage are the major restraints of the global hematology market.
The global hematology diagnostics market is segmented based on products, end-user and geography. Based on product type, the global hematology diagnostics market is further segmented into hematology analyzers and hematology reagents market. Hematology analyzers perform complete blood counts, coagulation or erythrocyte sedimentation rates (ESRs) tests.Automated hematology analyzers play an important role in transfusion medicine and in blood banks to perform quality check of blood samples and to screen the donors. There is a significant market shift of the hematology diagnostics instruments from manual testing to semi-automated or fully automated instruments.The manufacturers compete mainly on the number of parameters measured, reagents consumed, style, and price. Based on end-user the global hematology diagnostics market is segmented into hospitals, clinical laboratories, and academicand research institutes among others.
Geographically, the global hematology diagnostics market is categorized into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA) and Latin America. North America dominated the global hematology diagnostics market due to increasing blood disorders, increasing ageing population. For instance, as per the U.S. Census Bureau by 2030, approximately 20% of the population in U.S. are projected to be 65 years and above. Moreover better accessibility and availability of testing services are set to drive the market in North America. Whereas, Asia Pacific is growing at a high CAGR due to improving healthcare infrastructure, large patient base, government initiatives, and due improved purchasing power of buyers.
Some of the key players in the global hematology diagnostics market are Beckman Coulter, Abbott Laboratories, HemoCue AB, HORIBA, Ltd., Siemens AG, Sysmex, Mindray Medical International Limited., Roche Diagnostics A/S, Bio-Rad Laboratories, Inc. among others.

Tuesday, 17 November 2015

Disposable Medical Sensors Market - Market Research Report, 2015 - 2023

The medical devices manufacturing companies are in a nonstop process of improving medical devices in terms of convenience, safety and most prominently, sterility. This sterility factor significantly led to the manufacturing of the disposable medical devices. The new sensor technology that senses as well as records changes in any electrical properties aided the creation of disposable medical sensors. The use of these sensors in medical sector strongly depends on the type of application. The various types of disposable medical sensors includes ingestible sensor, implantable sensors, and invasive sensors.An ingestible digital sensor isswallowed in a pill for tracking health data from inside the human body. Implantable sensors are mainly used in medical research for measuring force, temperature, and pressure inside the human body.Invasive sensors are used for detection of physical as well as chemical parameters by inserting a probe inside a human body.
In medical diagnostics, sensors are necessary in digital thermometers, digital blood pressure meters, breath analyzers, peak flow meters, spirometers, sleep apnea monitoring devices and respiration pulse oximeters. The therapeutic equipment such asheart-lung machines, respiration equipment and anesthetic equipment in intensive care, as well as infusion and transfusion pumps use these disposable sensors. Therapeutic sleep apnea devices and dialysis systems are the further examples of therapeutic equipment which in turn rises the sensors demand.
On the basis of technologies, the disposable medical sensors are categorized into temperature, pressure, image, acoustic, gas, and flow sensors. Disposable blood pressure sensors are used for continuous patient’s blood pressure monitoring during the surgery.They are plugged in to a monitor which then shows the patients’ vital information. Pressure sensors are also used in intensive-care units (ICU), however must be replaced in every 24 hours. The image sensors along with camerascan be used for optical, X-ray and ultrasonic purposes in hospitals and clinics.
The global demand of wireless wearable,and disposable medical sensors continues to increase in a significant manner. In May 2012, the Federal Communications Commission (FCC)eliminated the protected broadband spectrum in the wireless medical sensor devices called medical body area networks (MBANs). These sensors monitor as well as read vital signs of a patient wirelessly. This decision was taken at the suggestion of Philips Healthcare, and GE Healthcare. FCC has also allocated 40 MHz of spectrum for MBAN devices to use on a shared and secondary basis.
The growing demand for sensors in clinics and in homes for treatment or diagnosis purpose is the major factor that is driving the global disposable medical sensors market. The increasing prevalence of chronic long term diseases such as cancer andkidney disorders along with rising incidences of infections in hospitals are propelling the need for global disposable medical sensors in medical sector. Also, thegrowing number of patients worldwide has significantly increased the adoption of disposable medical sensors among end-users. In addition, the rising government provisions, huge investments in healthcare sector and technological developmentssuch as wearable wrist watch devices as well asdisease detectiondevices are further expected to fuel the growth of global disposable medical sensors market.
Companies in disposable medical sensors market are coming up with various product launches along with innovations in order to tailor with rising and varying demand among end-users. For instance, in July 2015, MEMSIC, Inc. launched MFC2030 Bi-Directional Flow Sensor for medical applications such as anesthesia, analytical instruments, and process control. In October 2014, Sensirion AG launched disposable liquid flow sensors for medical devices. They are intelligent, compact as well as cost-effective disposable flow sensors. These sensors provide liquid flow measurement capability inside a medical tubing, such as catheter or infusion set on a real time basis.
Some of the key players in disposable medical sensors market are Sensirion AG, MEMSIC, Inc., Measurement Specialties, ST Microelectronics, Smiths Medical, Philips Healthcare, Freescale Semiconductor, Inc., Medtronic, GE Healthcare, Analog Devices, Inc., Honeywell International, Inc. Given Imaging Ltd., and Coividien, plc.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/ 

Research on Laser Capture Microdissection (LCM) Market - 2015 - 2023

Laser capture microdissection (LCM) is an automated sample preparation technique that enables isolation of specific cells from a mixed population under microscopic visualization. LCM technology can harvest the cells of interest directly or can isolate specific cells by cutting away unwanted cells to give histologically pure enriched cell populations. Laser capture microdissection technique of isolation of pure sample from a heterogeneous mixture allows, more efficient and accurate results with applications in downstream microgenomics such as next-generation sequencing, Sanger sequencing, cDNA library generation, RNA transcript profiling, PCR, proteomics and others. The major factors driving the laser capture microdissection market include increasing technical advantages of LCM in the field of biotechnology and biopharmaceutical development, increasing R&D funding, and rise in healthcare expenditure. While, factors such as lack of professionals with high technical expertise, and the high manufacturing and maintenance costs of equipment and accessories are the major factors restraining the growth of this market.
The global laser capture microdissection market has been segmented into product type, system type, application and geography. On basis of product type, the market has been categorized into instruments, consumables and software and services. The instruments sub-segment accounted for the largest market in the products segment during the forecast period. While software and services segment is the rapidly growing sub-segment. On the basis of application, the LCM market is sub-segmented into oncological research, neurological research, biotherapeutic development, and others. The system type segment is further categorized into infrared LCM systems, ultraviolet LCM systems, ultraviolet and infrared LCM systems and immunofluorescence LCM systems. The ultraviolet and infrared LCM system is the fastest growing sub-segment in the system type segment due to its feature such as efficient isolation of cells without changing morphology or biological integrity of the cell.
Geographically, the global laser capture microdissection market has been divided into five major regions such as North America, Europe, Asia Pacific, Latin America and Rest of the World. North America accounted for the major share in the global laser capture microdissection market during the forecast period. The factors supporting the market dominance of the region include growing pharmaceutical companies and contract research organization (CROs). Moreover, rising prevalence of various cancers (colon cancer, breast cancer, prostate cancer, and cervical cancer) in the region, extensive technological advancements and major market players located in this region, investment in life science research and development have surged in the recent past as well as collaborations have led to recent advances in the laser capture market in North America. Europe was the second largest laser capture microdissection market due to rising trend of utilization of nanomedicine in diagnostics, targeted drug delivery, clinical trials and drug development studies driving the demand for laser capture microdissection market. Asia-Pacific is observed to be an emerging market in laser capture microdissection and is still in the initial stage. Outsourcing clinical trials to Asian countries by majority of the drug development companies is one of the important factors driving the growth in the Asia-Pacific market. Furthermore, expansion of leading laser capture microdissection companies and increased R&D spending, rise in demand of protein therapeutics, emerging markets across India and China, and increasing demand from applied markets are likely to create opportunities for market growth. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, high disposable income and rising CRO’s in the region.
Some of the major players operating in this market include 3DHISTECH Ltd., AvanSci Bio LLC, DeNova Sciences Pte. Ltd., Danaher Corporation, Carl Zeiss AG, Molecular Machines & Industries, INDIVUMED GmbH, Ocimum Biosolutions LLC, Thermo Fisher Scientific, Inc., Theranostics Health Inc., and others
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/